Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria

BACKGROUND: Chloroquine has been recommended for Plasmodium vivax infections for >60 years, but resistance is increasing. To guide future therapies, the cumulative benefits of using slowly eliminated (chloroquine) vs rapidly eliminated (artesunate) antimalarials, and the risks and benefits of add...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Cindy S, Phyo, Aung Pyae, Lwin, Khin Maung, Win, Htun Htun, San, Thida, Aung, Aye Aye, Raksapraidee, Rattanaporn, Carrara, Verena I, Bancone, Germana, Watson, James, Moore, Kerryn A, Wiladphaingern, Jacher, Proux, Stéphane, Sriprawat, Kanlaya, Winterberg, Markus, Cheah, Phaik Yeong, Chue, Amy L, Tarning, Joel, Imwong, Mallika, Nosten, François, White, Nicholas J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206118/
https://www.ncbi.nlm.nih.gov/pubmed/29889239
http://dx.doi.org/10.1093/cid/ciy319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206118/
https://www.ncbi.nlm.nih.gov/pubmed/29889239
http://dx.doi.org/10.1093/cid/ciy319

Ejemplares similares